A new prognostic scoring system for newly diagnosed multiple myeloma in the era of new drugs
BackgroundWe developed a new predictive staging system to explore the heterogeneity of survival in newly diagnosed multiple myeloma (NDMM) patients in the real world.MethodsIn this retrospective study, we evaluated the predictive value of cytogenetic abnormal and clinical data in 375 patients with N...
Saved in:
| Main Authors: | Ye Li, Junru Liu, Jingjing Deng, Yuan Jian, Zhiyao Zhang, Huixing Zhou, Juan Li, Wenming Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-10-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1473034/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
by: Francesca Fazio, et al.
Published: (2023-08-01) -
The efficacy of new drug regimens in treating newly diagnosed high-risk cytogenetic multiple myeloma patients: a systematic literature review and meta-analysis
by: Huixing Zhou, et al.
Published: (2025-05-01) -
Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR study
by: Dipal Mehta, et al.
Published: (2025-06-01) -
A comprehensive analysis of bone marrow-derived cytogenetic abnormalities in multiple myeloma patients with extramedullary disease
by: Juan Xu, et al.
Published: (2025-05-01) -
Cytogenetic risk stratification combined with minimal residual disease status influences the therapeutic outcome and prognosis of multiple myelomas
by: Jianping Mao, et al.
Published: (2025-04-01)